Loading...
机构名称:
¥ 1.0

●本演示文稿包括具有重大风险和不确定性的前瞻性陈述,这些陈述可能导致实际结果与此类陈述所表达或暗示的结果有实质性差异。不能保证临床研究成功的管道产品,这些产品将获得必要的监管批准,或者证明它们将在商业上取得成功。如果基本假设证明不准确,风险或不确定性实现,则实际结果可能与前瞻性陈述所规定的或暗示的结果有重大差异。Additional information regarding these and other factors can be found in Pfizer's Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in our subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov和www.pfizer.com。

Pfizer Pipeline

Pfizer PipelinePDF文件第1页

Pfizer PipelinePDF文件第2页

Pfizer PipelinePDF文件第3页

Pfizer PipelinePDF文件第4页

Pfizer PipelinePDF文件第5页

相关文件推荐

2023 年
¥1.0
2021 年
¥1.0
2023 年
¥8.0
2024 年
¥1.0